
Developing Resistant Models to Diverse ADC Drugs
Antibody‒drug conjugates (ADCs), which combine the advantages of monoclonal antibodies with precise targeting and payloads, show great potential as cancer...
Continue ReadingAntibody‒drug conjugates (ADCs), which combine the advantages of monoclonal antibodies with precise targeting and payloads, show great potential as cancer...
Continue ReadingAbstract: Emerging as a major global health concern, metabolic dysfunction-associated steatohepatitis (MASH) is closely linked to obesity, type 2 diabetes,...
Continue ReadingIntroduction In recognition of International Women’s Day, we spotlight women’s health—a continuously evolving global healthcare issue. The year 2025 marks...
Continue ReadingIntroduction: Women spend about one-third of their lives in menopause or post-menopause, a period that marks the gradual decline of...
Continue ReadingDNA-encoded library (DEL) technology has been recognized as a major screening method with unique advantages for offering vast chemical diversity...
Continue ReadingChemical inducers of proximity (CIPs) are small molecules that induce the proximity of two biological targets, usually proteins. Molecular glues...
Continue ReadingWith advancements in drug design, there is resurging interest in drugs that form covalent bonds with their targets. Covalent drugs...
Continue ReadingKidney diseases are complex conditions caused by a variety of factors, including autoimmune diseases, metabolic disorders, infections, drug side effects,...
Continue ReadingRNA-targeted therapeutics are highly intriguing due to their unique physiological properties and novel modes of action in drug R&D. Developing...
Continue Reading